Viking Therapeutics Inc [VKTX] stock prices are up 8.92% to $38.57 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The VKTX shares have gain 6.34% over the last week, with a monthly amount glided 11.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Viking Therapeutics Inc [NASDAQ: VKTX] stock has seen the most recent analyst activity on October 29, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $106. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on April 29, 2025, and set its price target to $104. On April 08, 2025, Goldman initiated with a Neutral rating and assigned a price target of $30 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $102 on February 13, 2025. Citigroup initiated its recommendation with a Neutral and recommended $38 as its price target on February 07, 2025. In a note dated November 22, 2024, B. Riley Securities initiated a Buy rating and provided a target price of $109 on this stock.
The stock price of Viking Therapeutics Inc [VKTX] has been fluctuating between $18.92 and $52.58 over the past year. Currently, Wall Street analysts expect the stock to reach $104.67 within the next 12 months. Viking Therapeutics Inc [NASDAQ: VKTX] shares were valued at $38.57 at the most recent close of the market. An investor can expect a potential return of 171.38% based on the average VKTX price forecast.
Analyzing the VKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.29 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.58 points at the first support level, and at 32.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 40.77, and for the 2nd resistance point, it is at 42.98.
Ratios To Look Out For
It’s worth pointing out that Viking Therapeutics Inc [NASDAQ:VKTX]’s Current Ratio is 28.34. On the other hand, the Quick Ratio is 28.34, and the Cash Ratio is 3.85.
Transactions by insiders
Recent insider trading involved Mancini Marianna, Chief Operating Officer, that happened on Oct 28 ’25 when 6185.0 shares were sold. Director, Rowland Charles A Jr completed a deal on Oct 27 ’25 to sell 60000.0 shares. Meanwhile, President & CEO Lian Brian sold 38989.0 shares on Oct 28 ’25.
